We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





KUKA Introduces Innovative Medical Robots for the Operating Room (OR) at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021
Print article
Image: LBR Med (Photo courtesy of KUKA AG)
Image: LBR Med (Photo courtesy of KUKA AG)
KUKA AG (Augsburg, Germany) presented new application examples for its robots in the medical technology sector at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

KUKA is a supplier of intelligent automation solutions and offers robotic solutions for the medical and healthcare sectors. Robot systems from KUKA are suitable for a wide range of applications in robotic medical technology: from diagnosis and operations to rehabilitation. At MEDICA 2021, KUKA presented innovative ideas for robot-based applications in medicine, such as the collaborative LBR Med which is perfectly suited for various tasks in the medical field, thanks to its sensitive sensor technology. From diagnostics to treatment and surgical interventions – the LBR Med stands out as a perfect assistant for diverse tasks in the field of healthcare. The sensitive seven-axis lightweight robot is flexible and easy to integrate into medical products for various medical activities. With its responsive sensors, comprehensive safety precautions, hygiene-optimized surfaces and a controller designed for direct collaboration with the human operator, it is ideally suited to applications in medical technology.

KUKA demonstrated some of the possible applications of the LBR Med with the help of a medical feature cell, for example with an ultrasound-demo and a spine application. An ultrasound probe attached to the flange was guided over the body, and KUKA demonstrated how the robot records the path and then repeats the learned path independently and with constant pressure. It also demonstrated how the robot can take a change in the surface into account and continued to follow the path with the appropriate adjustment.

Additionally, KUKA’s long-time partner BEC presented guidoo - a robot-assisted surgical assistance system. The system is based on the LBR Med and enables safe and precise tissue removal during percutaneous interventions, i.e. the insertion of needles under the skin. This relieves doctors and minimizes collateral tissue damage.

Related Links:
KUKA AG

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Gastrointestinal Infection Test
RIDA QUICK Cryptosporidium/Giardia/Entamoeba Combi Test
New
snRNP-C Test
Chorus snRNP-C Test

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.